Mcdonald Partners LLC Spectrum Pharmaceuticals Inc Transaction History

Mcdonald Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$0.65 - $1.31 $9,135 - $18,410	-14,054 Reduced 41.03%	20,199 $19,000
Q1 2023 Apr 19, 2023	SELL	$0.38 - $1.07 $2,362 - $6,652	-6,217 Reduced 15.36%	34,253 $25,000
Q4 2022 Jan 18, 2023	SELL	$0.32 - $0.52 $672 - $1,092	-2,100 Reduced 4.93%	40,470 $0
Q1 2022 Apr 29, 2022	BUY	$0.63 - $1.59 $26,819 - $67,686	42,570 New	42,570 $55,000
Q4 2021 Jan 31, 2022	SELL	$1.27 - $2.42 $56,984 - $108,585	-44,870 Closed	0 $0
Q2 2021 Jul 23, 2021	BUY	$2.89 - $4.45 $289 - $445	100 Added 0.22%	44,870 $168,000
Q4 2020 Feb 16, 2021	BUY	$3.38 - $5.14 $151,322 - $230,117	44,770 New	44,770 $153,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Mcdonald Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Mcdonald Partners LLC with notifications on news.